Agomab Therapeutics
AGMB
#6773
Rank
A$0.89 B
Marketcap
A$18.25
Share price
-1.59%
Change (1 day)
N/A
Change (1 year)

Agomab Therapeutics (AGMB) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$31.65 Million

According to Agomab Therapeutics 's latest financial reports the company's total liabilities are A$31.65 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Agomab Therapeutics - Total liabilities on balance sheet (from 2024 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$30.57 M-4.94%
2023-12-31A$32.16 M-41.27%
2022-12-31A$54.77 M-15.79%
2021-12-31A$65.03 M